Doctors have begun a phase three trial of the world's first personalized mRNA vaccine against melanoma on hundreds of patients. It has every chance of permanently curing people from cancer, reports the Guardian. Melanoma affects about 132 people per year worldwide. This is one of…
Researchers have developed a new cell therapy vaccine to eliminate existing tumors and induce long-term ones. The patient receives temporary immunity, which trains the immune system so that it can prevent cancer from recurring, according to NeuroscienceNews. Scientists are using a new way to turn cancer cells into powerful anti-cancer agents.…